(PDF) Mechanism of Topoisomerase II Inhibition by

Mechanism of Topoisomerase II Inhibition by Staurosporine and Other Protein Kinase Inhibitors

Journal of Biological Chemistry - United States

doi 10.1074/jbc.271.42.26418

Full Text

Open PDF

Abstract

Available in full text

Date

October 18, 1996

Authors

Piotr Lassota

Guyanand Singh

Robert Kramer

Publisher

American Society for Biochemistry & Molecular Biology (ASBMB)

Related search

Inhibition of Angiogenesis by Staurosporine, a Potent Protein Kinase Inhibitor.

Journal of Antibiotics

Drug Discovery

Pharmacology

1992

English

Effects of Staurosporine, K 252a and Other Structurally Related Protein Kinase Inhibitors on Shape and Locomotion of Walker Carcinosarcoma Cells

British Journal of Cancer

Cancer Research

Oncology

1992

English

Human Multiple Myeloma Cells Are Sensitized to Topoisomerase II Inhibitors by CRM1 Inhibition

Cancer Research

Oncology

2009

English

Differential Regulation of NF-κB Activation and Function by Topoisomerase II Inhibitors

English

DNA Topoisomerase I Inhibitors: Chemistry, Biology, and Interfacial Inhibition

Chemical Reviews

Chemistry

2009

English

Inotropic Effects of Staurosporine, NA 0345 and H-7, Protein Kinase C Inhibitors, on Rabbit Ventricular Myocardium: Selective Inhibition of the Positive Inotropic Effect Mediated by .ALPHA.1-Adrenoceptors.

The Japanese Journal of Pharmacology

1993

English

The Inhibition of Cellular Recovery in Human Tumour Cells by Inhibitors of Topoisomerase

British Journal of Cancer

Cancer Research

Oncology

1990

English

Inhibition of Ca2+/Calmodulin-Dependent Protein Kinase II by Arachidonic Acid and Its Metabolites.

Proceedings of the National Academy of Sciences of the United States of America

Multidisciplinary

1989

English

Proteasomal Inhibition Stabilizes Topoisomerase IIα Protein and Reverses Resistance to the Topoisomerase II Poison Ethonafide (AMP-53, 6-Ethoxyazonafide)

Biochemical Pharmacology

Biochemistry

Pharmacology

2008

English

Amanote Research

Mechanism of Topoisomerase II Inhibition by Staurosporine and Other Protein Kinase Inhibitors

Journal of Biological Chemistry - United States

doi 10.1074/jbc.271.42.26418

Full Text

Abstract

Categories

Date

Authors

Publisher

Related search

Inhibition of Angiogenesis by Staurosporine, a Potent Protein Kinase Inhibitor.

Effects of Staurosporine, K 252a and Other Structurally Related Protein Kinase Inhibitors on Shape and Locomotion of Walker Carcinosarcoma Cells

Human Multiple Myeloma Cells Are Sensitized to Topoisomerase II Inhibitors by CRM1 Inhibition

Differential Regulation of NF-κB Activation and Function by Topoisomerase II Inhibitors

DNA Topoisomerase I Inhibitors: Chemistry, Biology, and Interfacial Inhibition

Inotropic Effects of Staurosporine, NA 0345 and H-7, Protein Kinase C Inhibitors, on Rabbit Ventricular Myocardium: Selective Inhibition of the Positive Inotropic Effect Mediated by .ALPHA.1-Adrenoceptors.

The Inhibition of Cellular Recovery in Human Tumour Cells by Inhibitors of Topoisomerase

Inhibition of Ca2+/Calmodulin-Dependent Protein Kinase II by Arachidonic Acid and Its Metabolites.

Proteasomal Inhibition Stabilizes Topoisomerase IIα Protein and Reverses Resistance to the Topoisomerase II Poison Ethonafide (AMP-53, 6-Ethoxyazonafide)